SCHEMBL5100674

SCHEMBL5100674

CCCCC#Cc1ccccc1C#Cc1ccccc1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
CYP1A2 P05177 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
CYP2D6 P10635 1/20 0.46
APEX1 P27695 1/20 0.46
TSHR P16473 4/20 0.42
ALDH1A1 P00352 3/20 0.40
KCNH2 Q12809 1/20 0.40
CYSLTR2 Q9NS75 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
HPGD P15428 2/20 0.39
ALOX12 P18054 1/20 0.39
PGK1 P00558 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5092518 0.95 KCNH2 (0.46) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL28622511 0.93 KCNH2 (0.47) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL5092526 0.84 CYP3A4 (0.43) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL5100838 0.82 TSHR (0.38) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL5100842 0.82 TSHR (0.38) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL10437184 0.82 CYP3A4 (0.49) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL6371432 0.81 KCNH2 (0.58) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL5092715 0.78 CYP3A4 (0.38) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL5092707 0.78 CYP3A4 (0.38) CYP3A4KDM4EMAPTCYP2C9CYP2C19
SCHEMBL10437176 0.77 CYSLTR2 (0.47) CYP3A4KDM4EMAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B CYP3A4 542/4885KDM4E 2951/4885MAPT 3753/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A CYP3A4 1065/4885KDM4E 2140/4885MAPT 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.